As shown in Fig. 2, the CD133+ glioblastoma cells showed a high invasive capacity, and had a significantly higher mean number of invasive cells in each high-power field (31.46±5.73), compared with the CD133− cells (2.47±0.53; P<0.05). The gene discussed is PROM1; the disease is glioblastoma.